Johns Hopkins Diabetes GuideComplications and ComorbiditiesGastrointestinal

Nonalcoholic Fatty Liver Disease

Mariana Lazo, M.D., Jeanne Clark, M.D.
Nonalcoholic Fatty Liver Disease is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or purchase a subscription.

Johns Hopkins Guides provide diagnosis, management, and treatment guidance for infectious diseases, diabetes, and psychiatric conditions. Explore these free sample topics:

Johns Hopkins Guides

~~ The first section of this topic is shown below ~~

DEFINITION

  • Nonalcoholic fatty liver disease (NAFLD): fatty infiltration (steatosis) of the liver, exceeding 5% of liver weight. In biopsy specimens, >5-10% macrosteatotic hepatocytes.
    • By definition, requires exclusion of alcohol as a potential cause. Acceptable levels of alcohol consumption are controversial but in general < 20 grams/day (2 drinks) in men and < 10 grams/day (1 drink) in women are considered safe, and below the cutoff associated with increased risk of cirrhosis (30 grams/day in men and 20 grams/day in women).
  • Primary NAFLD: common term for typical NAFLD associated with central obesity and/or type 2 diabetes (T2DM) or insulin resistance (IR), without another specific etiology.
  • Secondary NAFLD: used to defined as NAFLD in the absence of insulin resistance and associated with other causes such as: polycystic ovary syndrome, hypothyroidism, hypogonadism, hypopituitarism, medication use (glucocorticoids, tamoxifen, amiodarone, HAART, diltiazem), disorders of lipid metabolism (abetalipoproteinemia, lipodystrophy, Weber-Christian syndrome, Andersen’s disease), total parenteral nutrition and jejunoileal bypass surgery. Many cases of "secondary" NAFLD likely represent an exacerbation of often unrecognized "primary" NAFLD.
  • Nonalcoholic steatohepatitis (NASH): the more severe form of NAFLD characterized by inflammation, hepatocyte injury (ballooned hepatocytes), with or without fibrosis. It can progress to cirrhosis and possibly liver cancer.
  • NASH cirrhosis: the presence of cirrhosis with current or previous evidence of steatosis or NASH.
  • Cryptogenic cirrhosis: a term used to define the presence of cirrhosis with no obvious etiology, however, frequently there is a history of diabetes and obesity.

~~ To view the remaining sections of this topic, please
or purchase a subscription ~~

Last updated: June 27, 2015